Analysis for TNF-α using solid-phase affinity capture with radiolabel and MALDI-MS detection

Gregory B. Hurst, Michelle V. Buchanan, Linda J. Foote, Stephen J. Kennel

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

Screening of mutant mice for subtle phenotypes requires sensitive, high- throughput analyses of sentinel proteins in functional pathways. The cytokine TNF-α is upregulated during inflammatory reactions associated with antoimmune diseases. We have developed a method to monitor the concentration of TNF-α under physiological conditions. TNF-α is captured, purified, and concentrated using monoclonal antibody-coated microbeads. The capture is efficient (>80%) and can be used in the concentration range <100 pg/mL to >50 ng/mL, as determined by detection of 125I-labeled TNF-α. The bead capture of TNF-α can be combined with direct detection by MALDI-MS for sample concentrations of > 10 ng/mL. TNF-α can be captured and detected from diluted mouse serum, with minimal interferences observed in the MALDI spectrum. This method is adaptable to high-throughput sample handling with microfluidic devices and automated mass spectrometric analysis.

Original languageEnglish
Pages (from-to)4727-4733
Number of pages7
JournalAnalytical Chemistry
Volume71
Issue number20
DOIs
StatePublished - Oct 15 1999

Fingerprint

Dive into the research topics of 'Analysis for TNF-α using solid-phase affinity capture with radiolabel and MALDI-MS detection'. Together they form a unique fingerprint.

Cite this